Antibiotic Therapy in the Diabetic Foot

Area of Science:

• Infectious Diseases
• Diabetology
• Pharmacology

Background:

• Diabetic foot infections (DFIs) are a significant complication of diabetes, often leading to severe morbidity.
• Effective management of DFIs requires careful consideration of multiple patient-specific and infection-related factors.

Purpose of the Study:

• To outline the principles of selecting and tailoring antimicrobial therapy for diabetic foot infections.
• To emphasize the importance of a stepwise approach, from empiric to targeted treatment, and appropriate duration.

Main Methods:

• Review of current guidelines and clinical evidence for managing DFIs.
• Consideration of factors influencing empiric therapy selection, including wound severity, comorbidities, allergies, and local resistance patterns.
• Discussion of tailoring therapy based on culture results and optimizing treatment duration.

Main Results:

• Empiric antimicrobial therapy selection should account for wound severity, patient comorbidities, allergies, prior cultures, risk factors for resistant organisms, and local antibiograms.
• Subsequent therapy can be refined based on culture results, and duration guided by surgical approach and pathology.
• Most patients can transition to oral step-down therapy after initial clinical improvement.

Conclusions:

• Optimizing antimicrobial therapy for DFIs involves a comprehensive, individualized approach.
• Treatment duration for soft tissue infections depends on severity, and for osteomyelitis, on surgical intervention.
• Effective management strategies can improve outcomes and reduce complications associated with diabetic foot infections.